Marked reduction in long-term cardiac deaths with aspirin after a coronary event
نویسندگان
چکیده
منابع مشابه
Editorial: Aspirin and Coronary Deaths
IN THIS ISSUE Hennekens, Karlson and Rosner report a lack of association between the frequent use of aspirin, defined as use . 4 days per week, and subsequent coronary heart disease (CHD) mortality. The experimental design was that of the retrospective, case-controlled study. The investigators surveyed the death certificates filed in two Florida counties over a 16-month period and identified th...
متن کاملLong-term cardiac survival after reoperative coronary artery bypass grafting.
OBJECTIVE Despite advances in cardiac surgery, the risk of reoperative coronary artery bypass surgery (RECABG) still exceeds those of a primary myocardial revascularization and also the late results are not so favourable. In this study, long-term cardiac survival is analyzed. METHODS We analyzed long-term cardiac survival of 466 patients who survived the first 6 months after a RECABG between ...
متن کاملRegular Aspirin Use and Coronary Deaths
Information was collected for a large number of coronary risk factors on a series of 568 married, white men, aged 30-70 years, who died from coronary heart disease. Information on the same risk factors was collected on an equal number of living controls matched on age, sex, marital status and neighborhood. For regular aspirin users (i.e., _ 4 days per week) compared with non-users, the crude ma...
متن کاملLong Term Follow up and Patient Satisfaction after Reduction Mammoplasty: Superomedial versus Inferior Pedicle
BACKGROUND Surgery for hypertrophied breast represents a challenge for plastic surgeons. The search for a good cosmetic breast has led to the development of many techniques. Objectives for reduction mammoplasty are to achieve elevated, symmetrical breasts, with round shape, good projection, small cicatrices that are not very perceptible, and a lasting result. METHODS This study was car...
متن کاملImpact of aspirin treatment on long-term outcome (over 10 years) after percutaneous coronary intervention.
Aspirin has been shown to reduce cardiovascular morbidity and mortality following percutaneous coronary intervention (PCI). However, its effects on long-term (over 10 years) mortality have not been fully elucidated. This retrospective study recorded the patient characteristics and admission medication for all patients undergoing PCI over an 8-year period from 1984 to 1992. Follow-up information...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 1996
ISSN: 0735-1097
DOI: 10.1016/0735-1097(96)00150-7